Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,001,933
-
Share change
-
+4,865,283
-
Total reported value
-
$34,005,890
-
Put/Call ratio
-
128%
-
Price per share
-
$4.25
-
Number of holders
-
56
-
Value change
-
+$22,167,621
-
Number of buys
-
40
-
Number of sells
-
12
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2022
As of 31 Dec 2022,
Summit Therapeutics Inc. - COM (SMMT) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,001,933 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MARSHALL WACE, LLP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Steward Partners Investment Advisory, LLC, AWM Investment Company, Inc., TWO SIGMA INVESTMENTS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.